NFKB1 and Stroke: D-4F treatment significantly (n=8/group, *p<0.05) decreases TLR4 (Figure 3a), MMP9 (Figure 3b) and nuclear NFκB (Figure 3c) expression compared to PBS treated T1DM stroke control rats at 48 hours after stroke.